Kumquat Biosciences: Co, Takeda Enter Strategic Collaboration, Exclusive Global License Agreement to Advance Novel Oral Immuno-Oncology Drug Candidate
Kumquat Biosciences: Co. 与武田进入战略合作,签订全球独家许可协议,以推进新的口服免疫肿瘤学候选药物
Kumquat Biosciences: Co, Takeda Enter Strategic Collaboration, Exclusive Global License Agreement to Advance Novel Oral Immuno-Oncology Drug Candidate
Kumquat Biosciences: Co. 与武田进入战略合作,签订全球独家许可协议,以推进新的口服免疫肿瘤学候选药物
译文内容由第三方软件翻译。